They had confidence that convalescent plasma has potential to benefit many sick patients and the safety profile is well defined.
-
-
Show this thread
-
We unfortunately do not have randomized trials for convalescent plasma but must make decisions based on what we do have from the Mayo Clinic expanded access program.
Show this thread -
The decision was based on significant data from the Mayo Clinic and other reliable sources plus a century of experience with convalescent plasma.
Show this thread -
We at FDA do not permit politics to enter into our scientific decisions. This happens to be a political season but FDA will remain data driven. On behalf of FDA‘s 18,000 career employees, I want to reassure the American public about this commitment.
Show this thread -
The convalescent plasma decision was made entirely by FDA scientists.
Show this thread -
The authorization of emergency use of convalescent plasma is not a final approval. FDA will continue to monitor its use and will revoke authorization if needed. We feel broader use of plasma will truly benefit many patients but will require further study.
Show this thread -
I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma. The criticism is entirely justified. What I should have said better is that the data show a relative risk reduction not an absolute risk reduction.
Show this thread
End of conversation
New conversation -
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Wonder where on earth they got the idea FDA has been politically compromised
pic.twitter.com/KLHCY7msoH
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
You should resignhttps://twitter.com/DeadlineWH/status/1298015928379211778 …
1:49Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
